Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Sherman

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2016
To TACE or not to TACE: that is the questionMorris Sherman
Journal of Hepatology|December 20, 2015
Staging for hepatocellular carcinoma: An embarrassment of richesMorris Sherman
Journal of Hepatology|July 23, 2003
Hepatocellular carcinoma: beyond screeningMorris Sherman
Gastroenterology & Hepatology|April 9, 2011
Current status of alpha-fetoprotein testingMorris Sherman
Hepatology (Baltimore, Md.)|April 1, 2011
Histological diagnosis of early hepatocellular carcinomaMorris Sherman
The American Journal of Gastroenterology|February 2, 2006
Optimizing management strategies in special patient populationsMorris Sherman
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 27, 2008
Hepatitis C: the juggernaut rolls on uncheckedMorris Sherman
Journal of Hepatology|April 17, 2010
The resurrection of alphafetoproteinMorris Sherman
Hepatology (Baltimore, Md.)|February 13, 2013
Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?Morris Sherman
Hepatology (Baltimore, Md.)|November 21, 2013
Screening for liver cancer: another piece of the puzzle?Morris Sherman
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2016
To TACE or not to TACE: that is the questionMorris Sherman
Journal of Hepatology|December 20, 2015
Staging for hepatocellular carcinoma: An embarrassment of richesMorris Sherman
Journal of Hepatology|July 23, 2003
Hepatocellular carcinoma: beyond screeningMorris Sherman
Gastroenterology & Hepatology|April 9, 2011
Current status of alpha-fetoprotein testingMorris Sherman
Hepatology (Baltimore, Md.)|April 1, 2011
Histological diagnosis of early hepatocellular carcinomaMorris Sherman
The American Journal of Gastroenterology|February 2, 2006
Optimizing management strategies in special patient populationsMorris Sherman
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 27, 2008
Hepatitis C: the juggernaut rolls on uncheckedMorris Sherman
Journal of Hepatology|April 17, 2010
The resurrection of alphafetoproteinMorris Sherman
Hepatology (Baltimore, Md.)|February 13, 2013
Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?Morris Sherman
Hepatology (Baltimore, Md.)|November 21, 2013
Screening for liver cancer: another piece of the puzzle?Morris Sherman
Pageof 16